[1] RamsayMA,SavageTM,Simpson BR,et a1. Controlled sedation with alphaxalone alphadolne[J].BMJ,1974,22(2):656-659. [2] Muellejans B,Lopez A,Cross M H,et al.Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit:a randomized,double-blind controlled trial[J].Crit Care,2004,8:R1-11. [3] Mantz J.Alpha2-adrenoceptoragonists:analgesia,sedation,anxiolysis,haemodynamies,respiratory function and weaning[J].Bailliere’s Clin Anaesthesiol,2000,14(2):443-448. [4] Ruotsalainen S, Haapalinna A, Riekkinen P J Sr,et al.Dexmedetomidine reduces response tendency,but not accuracy of rats in attention and short-term memory tasks[J].Pharmacology Biochemistry Behavior,1997,56(1):31-40. [5] Aantaa R. Assessment of the sedative effects of dexmedetomidine,an alpha 2-adrenoceptor agenist,with analysis of saccadie eye movements[J].Pharmacology Toxicology ,1991,68(5):394-398. [6] Furst S R,Weinger M B. Dexmedetomidine, a selective alpha 2-agonist,does not potentiate the cardiorespiratory depression of alfentanil in the rat[J].Anesthesiology,1990,72(5):882-888. [7] Mantz J .Phase Ⅲstudy on dexmedetomidine used for postoperative sedation of patients requiting mechanical ventilation for less than 24 hours:the rench xperience[J].Middle st JAnesthesiology,2002,16(6):597-606. [8] Anttila M,Penthla J,Helmlnen A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects[J].Br J ClinPharmacol,2003,56(6):691-693. |